Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (331-340 of 380) with videos related to

Pageof 38
Sort By:
Lancet (London, England)|June 30, 1990
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorM Galli, P Comfurius, C Maassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemiaA Z Rohatiner, R Bassan, R Raimondi, et al.
British Journal of Haematology|February 13, 2001
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyR Chopra, J D Eaton, A Grassi, et al.
Leukemia|July 13, 2007
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burdenA M Vannucchi, E Antonioli, P Guglielmelli, et al.
Leukemia|May 1, 1996
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemiasA Rambaldi, P Viero, R Bassan, et al.
Haematologica|December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical studyR Bassan, E Pogliani, T Lerede, et al.
Blood|March 1, 1996
Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemiasJ Golay, M Luppi, S Songia, et al.
Acta Neurologica Scandinavica|August 19, 2000
Recurrence after first cerebral infarction in young adultsM Camerlingo, L Casto, B Censori, et al.
Annals of Internal Medicine|June 1, 1994
Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin BF Menichetti, A Del Favero, P Martino, et al.
Leukemia|October 15, 2016
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendationsM Marchetti, G Barosi, F Cervantes, et al.
Pageof 38

Showing results (331-340 of 380) with videos related to

Sort By:
Pageof 38
Lancet (London, England)|June 30, 1990
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorM Galli, P Comfurius, C Maassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemiaA Z Rohatiner, R Bassan, R Raimondi, et al.
British Journal of Haematology|February 13, 2001
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyR Chopra, J D Eaton, A Grassi, et al.
Leukemia|July 13, 2007
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burdenA M Vannucchi, E Antonioli, P Guglielmelli, et al.
Leukemia|May 1, 1996
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemiasA Rambaldi, P Viero, R Bassan, et al.
Haematologica|December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical studyR Bassan, E Pogliani, T Lerede, et al.
Blood|March 1, 1996
Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemiasJ Golay, M Luppi, S Songia, et al.
Acta Neurologica Scandinavica|August 19, 2000
Recurrence after first cerebral infarction in young adultsM Camerlingo, L Casto, B Censori, et al.
Annals of Internal Medicine|June 1, 1994
Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin BF Menichetti, A Del Favero, P Martino, et al.
Leukemia|October 15, 2016
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendationsM Marchetti, G Barosi, F Cervantes, et al.
Pageof 38